• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Tolan Mary A

    12/7/21 9:09:23 PM ET
    $FORE
    Finance
    Get the next $FORE alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    TOLAN MARY A

    (Last) (First) (Middle)
    C/O P3 HEALTH PARTNERS INC.
    2370 CORPORATE CIRCLE, SUITE 300

    (Street)
    HENDERSON NV 89074

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    12/03/2021
    3. Issuer Name and Ticker or Trading Symbol
    P3 Health Partners Inc. [ PIII ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit 24 - Power of Attorney
    No securities are beneficially owned.
    /s/ Jessica Puathasnanon, as attorney-in-fact 12/07/2021
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $FORE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FORE

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FORE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • P3 Health Partners Closes Business Combination with Foresight Acquisition Corp. and Will Begin Trading on the Nasdaq

      NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- P3 Health Partners ("P3" or "Company"), a patient-centered and physician-led population health management company, announced today that it has closed its previously announced business combination with Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight"). The transaction was approved at a special meeting of Foresight's stockholders on December 3, 2021. The combined company will be named P3 Health Partners Inc. and will be led by P3's management team. Its shares of Class A common stock and warrants are expected to begin trading December 6, 2021, on the Nasdaq under the ticker symbols "PIII" and "PIIIW", respectively. "At P3, we utilize our pro

      12/3/21 5:24:12 PM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

      NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") that was initially convened at 9:00 a.m. Central Time on November 18, 2021 and adjourned to today, was reconvened today at 7:00 a.m. Central Time and further adjourned until 7:00 a.m. Central Time on December 3, 2021. As anticipated, the Special Meeting was further adjourned to provide Foresight and P3 additional time to file a proxy supplement to the definitive proxy statement that was filed with the

      11/24/21 10:39:40 AM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. (NASDAQ:FORE) and P3 Health Partners Announce Adjournment of Special Meeting for Proposed Business Combination

      NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Foresight Acquisition Corp. (NASDAQ:FORE) ("Foresight") announced that its Special Meeting of Foresight's stockholders (the "Special Meeting") relating to the proposed business combination (the "Business Combination") with P3 Health Partners ("P3") was convened today at 9:00 a.m. Central Time and adjourned until 7:00 a.m. Central Time on November 24, 2021. The Special Meeting was adjourned to give Foresight's stockholders additional time to consider additional disclosure to be included in a supplement to the Proxy Statement that was filed with the Securities and Exchange Commission ("SEC") on October 28, 2021 (the "Proxy Statement") and mailed to

      11/18/21 11:02:22 AM ET
      $FORE
      Finance

    $FORE
    SEC Filings

    See more
    • Foresight Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant’s Certifying Accountant, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Change in Shell Company Status, Regulation FD Disclo

      8-K - P3 Health Partners Inc. (0001832511) (Filer)

      12/9/21 5:17:10 PM ET
      $FORE
      Finance
    • Foresight Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Foresight Acquisition Corp. (0001832511) (Filer)

      12/3/21 4:48:34 PM ET
      $FORE
      Finance
    • SEC Form 25-NSE filed by Foresight Acquisition Corp.

      25-NSE - Foresight Acquisition Corp. (0001832511) (Subject)

      12/3/21 4:31:22 PM ET
      $FORE
      Finance

    $FORE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/17/21 4:08:59 PM ET
      $FORE
      Finance
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/13/21 5:24:05 PM ET
      $FORE
      Finance
    • SEC Form SC 13D filed by Foresight Acquisition Corp.

      SC 13D - P3 Health Partners Inc. (0001832511) (Subject)

      12/13/21 4:17:19 PM ET
      $FORE
      Finance

    $FORE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Hudson Vegas Investment Spv, Llc claimed ownership of 43,974,331 units of Class V Common Stock

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      12/17/21 6:00:35 PM ET
      $FORE
      Finance
    • SEC Form 3: New insider Chicago Pacific Founders Ugp, Llc claimed ownership of 8,732,517 shares and claimed ownership of 91,269,317 units of Class V Common Stock (Amendment)

      3/A - P3 Health Partners Inc. (0001832511) (Issuer)

      12/13/21 4:50:43 PM ET
      $FORE
      Finance
    • SEC Form 3: New insider Chicago Pacific Founders Ugp, Llc claimed ownership of 91,269,317 units of Class V Common Stock and claimed ownership of 8,872,593 shares

      3 - P3 Health Partners Inc. (0001832511) (Issuer)

      12/7/21 9:21:55 PM ET
      $FORE
      Finance